Lenskart Solutions IPO is fully book build issue and total IPO size is ₹2150.00 crores. The entire share offering is a fresh issue worth ₹2150.00 crores.
The dates for the Lenskart Solutions IPO have not been announced yet. The allotment process is expected to be finalized by [.].
The Lenskart Solutions IPO is scheduled to list on BSE, NSE, with a listing date of [.]. The price band for the Lenskart Solutions IPO has not been announced yet.
Registrar for this IPO is Mufg Intime India Private Limited (Formerly Link Intime India Private Limited ) and lead managers for Lenskart Solutions IPO are Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Avendus Capital Private Limited, Citigroup Global Markets India Private Limited, Axis Capital Limited, Intensive Fiscal Services Private Limited.
IPO Schedule
IPO Open Date | - |
---|---|
IPO Close Date | - |
IPO Allotment Date | - |
Refund Initiation | - |
Share credit in Demat | - |
Listing Date | - |
Key Details
Price Band | TBA |
---|---|
Lot Size | TBA |
Face Value | ₹2 Per Equity Share |
Total Issue Size | 132,288,941 Shares + ₹2,150 Crores |
Fresh Issue | ₹2,150.00 Crores |
OFS Issue | 132,288,941 Shares |
Issue Type | Fresh Issue and Offer for Sale |
Listing At | BSE, NSE |
Share Reservation
Investor Category | Shares Offered |
---|---|
QIB | 75% |
Retail | 10% |
NII/HNI | 15% |
About Lenskart Solutions Limited Company
Lenskart aims to provide accessible and quality eyewear through technology-driven supply and distribution solutions. As a technology-driven eyewear company, Lenskart's integrated operations span designing, manufacturing, branding, and retailing. They primarily sell prescription eyeglasses, sunglasses, contact lenses, and accessories.
India is Lenskart's largest market, and according to the Redseer Report, it is the largest seller of prescription eyeglasses in terms of volumes sold in India in Financial Year 2025. Leveraging its experience and capabilities in India, Lenskart has expanded into select international markets including Japan, Southeast Asia and the Middle East. Lenskart is the largest, and in Asia, is amongst the two largest, organized retailers of prescription eyeglasses in terms of B2C eyeglasses sales volumes during the Financial Year 2025, according to the Redseer Report.
Lenskart designs and sells a wide range of eyewear products under their own brands and sub-brands. In Financial Year 2025, Lenskart launched 105 new in-house designed and engineered collections globally. As of March 31, 2025, Lenskart's mobile applications had over 100 million cumulative downloads, and they operated through 2,723 stores globally (comprising 2,067 stores in India and 656 stores internationally). During the Financial Years 2025, 2024 and 2023, Lenskart had revenue from operations amounting to ₹665.25 crore, ₹542.77 crore, and ₹378.80 crore respectively, reflecting a year-on-year growth of 22.57% between Financial Years 2025 and 2024, and 43.29% between Financial Year 2024 and 2023.
Lenskart Solutions Limited Financial Details
Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
---|---|---|---|
Assets | 10471.02 | 9531.02 | 9528.28 |
Revenue | 6652.52 | 5427.70 | 3788.03 |
Profit After Tax | 297.34 | (10.15) | (63.76) |
Net Worth | 6206.17 | 5755.95 | 5569.79 |
Reserves and Surplus | 5777.30 | 5466.91 | 5441.28 |
Total Borrowing | 345.94 | 497.15 | 917.21 |
₹ In Crore
Key Performance Indicator
Basic EPS (in ₹) | Return on Net Worth (RoNW) | Net Asset Value (NAV) | Debt-Equity Ratio | Return on Equity (ROE) | Return on Capital Employed (ROCE) |
---|---|---|---|---|---|
1.77 | 4.84 | 36.43 |
Offer Objectives
The offer objects include details of options granted, vested, exercised, forfeited and outstanding under the employee stock option plans. For the period commencing April 1, 2025, until the date of the Draft Red Herring Prospectus (DRHP), there were 9,579,812 options outstanding with an exercise price of ₹230.00. The weighted average exercise price of outstanding options is ₹134.89.
Key Managerial Personnel (KMP) such as Ramneek Khurana were granted a significant number of options. As of July 28, 2025, no options have been granted under the Lenskart ESOP 2025. The objects of Lenskart ESOP 2025 are to create a sense of ownership, attract, retain, and motivate employees of the organization; and reward employees with ownership in proportion to their contribution.
The fresh issue proposes a gross proceed of ₹2,150 crore. The company plans to utilize the net proceeds for capital expenditure towards new CoCo stores in India (₹272.622 crore), lease/rent payments for CoCo stores (₹591.44 crore), investments in technology and cloud infrastructure (₹213.375 crore), brand marketing (₹320.063 crore), and unidentified inorganic acquisitions and general corporate purposes. The deployment is scheduled over Financial Years 2026-2029, with significant portions allocated to store expansion and technology.
Company Details
Address:
Registered Office : Plot No. 151, Okhla Industrial Estate, Phase III, New Delhi 110 020, Delhi, India
Corporate Office : Ground Floor Vipul Tech Square, Golf Course Road Sector 4 3, DLF QE, Gurugram 122 0 09, Haryana, India
Phone: +91 124 429 3191
Email: [email protected]
Website: https://www.lenskart.com
IPO Registrar Details
Mufg Intime India Private Limited (Formerly Link Intime India Private Limited )
Phone: +91 81081 14949
Email: [email protected]
Website: http://www.%20in.mpms.mufg.com/
Offer Prospectus & Documents
Lead Managers
- Kotak Mahindra Capital Company Limited
- Morgan Stanley India Company Private Limited
- Avendus Capital Private Limited
- Citigroup Global Markets India Private Limited
- Axis Capital Limited
- Intensive Fiscal Services Private Limited